PUBLISHER: Polaris Market Research | PRODUCT CODE: 1078387
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1078387
The global pharmacovigilance market size is expected to reach USD 15.84 Billion by 2030 according to a new study by Polaris Market Research. The report "Pharmacovigilance Market Share, Size, Trends, Industry Analysis Report, By Service, By Product Life Cycle, By Type, By Process Flow, By Therapeutic Area, By End-Use, By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The primary drivers of the market include rising medication intake novel drug development frequencies, rising prices of negative drug responses and drug toxicities, as well as an expanding tendency of contracting pharmacovigilance solutions is expected to boost the industry growth. Moreover, the pharmaceutical sector's excessive expenditure, rising incidence of adverse drug events, and drug mistakes are propelling the industry forward. Furthermore, the coronavirus pandemic has produced an emergency demand for a vaccine that has offered several chances for industry participants.
The contract outsources segment is expected to hold the major shares in the global market during the forecast period due to its benefits such as transforming fixed supply costs into variables, refining on-demand contact to distinctive expertise along with other benefits.
North America is expected to hold the major share in the global market over the forecast period due to increasing investment by the industry players in introducing novel drugs. Moreover, stringent regulations along with the presence of advanced healthcare systems in countries like the U.S. and Canada are expected to create lucrative opportunities for industry growth.
Some of the major players operating in the global market are ArisGlobal, Accenture, BioClinica, Inc., United BioSource Corporation, Clinquest Group B.V. (Linical Americas), Cognizant, Capgemini, FMD K&L, IBM Corporation, IQVIA, ICON Plc., ITClinical, Linical Accelovance, PAREXEL International Corporation, Laboratory Corporation of America Holdings, TAKE Solutions, and Wipro Limited.
Polaris Market Research has segmented the pharmacovigilance market report on the basis of service provider, product life cycle, type, process flow, therapeutic area, end-use, and region:
Pharmacovigilance, Service Provider Outlook (Revenue - USD Billion, 2018 - 2030)
In-house
Contract Outsourcing
Pharmacovigilance, Product Life Cycle Outlook (Revenue - USD Billion, 2018 - 2030)
Pre-clinical
Phase I
Phase II
Phase III
Phase IV
Pharmacovigilance, Type Outlook (Revenue - USD Billion, 2018 - 2030)
Spontaneous Reporting
Intensified ADR Reporting
Targeted Spontaneous Reporting
Cohort Event Monitoring
EHR Mining
Pharmacovigilance, Process Flow Outlook (Revenue - USD Billion, 2018 - 2030)
Case Data Management
Case Logging
Case Data Analysis
Medical Reviewing & Reporting
Signal Detection
Adverse Event Logging
Adverse Event Analysis
Adverse Event Review & Reporting
Risk Management System
Risk Evaluation System
Risk Mitigation System
Pharmacovigilance, Therapeutic Area Outlook (Revenue - USD Billion, 2018 - 2030)
Oncology
Neurology
Cardiology
Respiratory Systems
Others
Pharmacovigilance, End-Use Outlook (Revenue - USD Billion, 2018 - 2030)
Pharmaceuticals
Biotechnology Companies
Medical Device Manufacturers
Others
Pharmacovigilance, Regional Outlook (Revenue - USD Billion, 2018 - 2030)
North America
U.S.
Canada
Europe
Germany
UK
Italy
France
Netherlands
Russia
Spain
Asia Pacific
China
Japan
India
Indonesia
Malaysia
South Korea
Latin America
Brazil
Argentina
Mexico
Middle East & Africa
Israel
Saudi Arabia
South Africa
UAE